Waddell & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
3,839
-139
-3% -$11.2K 0.02% 383
2026
Q1
$333K Buy
3,978
+517
+15% +$38.9K 0.02% 314
2025
Q4
$232K Buy
+3,461
New +$224K 0.02% 329

Other funds holding CTVA

Waddell & Associates's CTVA Position: Q2 2026 in Review

Waddell & Associates reduced its Corteva (CTVA) stake by 3.5% in Q2 2026, selling an estimated $11.2K and leaving 3,839 shares worth $325K. The position accounts for 0.02% of the portfolio, ranked #383.

Waddell & Associates first reported a position in CTVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $333K in Q1 2026. 528 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Waddell & Associates held 3,839 shares of Corteva worth $325K as of Q2 2026.
  • Waddell & Associates sold 139 Corteva shares in Q2 2026, an estimated $11.2K.
  • Corteva made up 0.02% of Waddell & Associates's portfolio in Q2 2026, its #383 holding.
  • Waddell & Associates first reported a position in Corteva in Q4 2025 and has held it in 3 quarters since.
  • Waddell & Associates's Corteva position peaked at $333K in Q1 2026.
  • 528 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.